Compare RGEN & OC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | OC |
|---|---|---|
| Founded | 1981 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 9.3B |
| IPO Year | N/A | N/A |
| Metric | RGEN | OC |
|---|---|---|
| Price | $141.49 | $136.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $177.18 | $149.92 |
| AVG Volume (30 Days) | 680.2K | ★ 1.5M |
| Earning Date | 02-19-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 2.33% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $707,890,000.00 | ★ $11,659,000,000.00 |
| Revenue This Year | $17.86 | N/A |
| Revenue Next Year | $12.44 | N/A |
| P/E Ratio | $4,604.96 | ★ N/A |
| Revenue Growth | 11.74 | ★ 21.69 |
| 52 Week Low | $102.97 | $97.53 |
| 52 Week High | $175.77 | $186.18 |
| Indicator | RGEN | OC |
|---|---|---|
| Relative Strength Index (RSI) | 30.69 | 71.06 |
| Support Level | $138.52 | $116.88 |
| Resistance Level | $160.88 | $134.86 |
| Average True Range (ATR) | 7.04 | 4.17 |
| MACD | -2.48 | 0.92 |
| Stochastic Oscillator | 10.87 | 89.74 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with four reportable segments: Composites, Insulation, Doors, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.